The university will offer four class formats and implement a range of safety measures on campus when the fall semester begins on Aug. 24 as scheduled with a mix of in-person and remote instruction.
Recent notices include appointments for curricular affairs, licensing, sleep medicine, research and student mental health, plus national awards for mentorship, diversity and pancreatic cancer studies.
A free statewide COVID-19 antibody testing program expands to 15 categories of essential workers at high risk of exposure, in concert with a $7.7 million UArizona study to better understand immunity.
In addition, Dr. Sweasy will serve as UArizona chief adviser on cancer-related matters and principal investigator of the National Cancer Institute Cancer Center Support Grant.
COVID Watch sends exposure alerts without having to collect any personally identifying information from users, protecting their anonymity.
University of Arizona president, Dr. Robert Robbins announced in April his plans to resume in-person classes Aug. 24, bringing back 45,000 students and 15,000 faculty and staff for fall 2020.
The University of Arizona – State of Arizona antibody testing initiative will include 31 sites across the state as it expands to all 15 counties.
UArizona Cancer Center, Banner – University Medicine continue state-of-the-art cancer care and cutting-edge clinical research during COVID-19 pandemic since “Cancer doesn’t sleep, so neither can we.”
Thirteen research teams will address various aspects of the COVID-19 pandemic with financial support from rapid-turnaround seed grants supplied through funding from the state and University of Arizona BIO5 Institute.
Concerned about how the pandemic will impact the homeless population, University of Arizona Health Sciences students are screening Tucson’s homeless for symptoms of COVID-19.
More than 70 University of Arizona medical students are helping health care professionals during the COVID-19 crisis by volunteering to provide child care, pet care, grocery shopping and more.
In coordination with the University of Arizona and College of Medicine – Phoenix, the College of Medicine — Tucson is offering early graduation to the Class of 2020. This option is for qualified students who wish to serve as new physicians to meet the unprecedented health needs that have emerged from the COVID-19 pandemic.
One-third of the UA College of Medicine – Tucson Class of 2020 will remain in Arizona to practice medicine and pursue their residency training. Nearly 50 percent of the class will pursue primary care — a physician specialty that is critically low in Arizona and the nation.
Out of an abundance of caution regarding the COVID-19 pandemic, the Sarver Heart Center at the University of Arizona College of Medicine – Tucson has canceled its Green Valley Lecture scheduled 10 a.m., Thursday, March 19.
The Match Day Ceremony hosted by the University of Arizona College of Medicine – Tucson has been canceled out of caution for student and employee welfare due to the COVID-19 pandemic. Instead, graduating medical students will celebrate in small groups and pick up envelopes that detail where they will begin their careers as physicians.
Dr. Hani Babiker, assistant director of early-phase therapeutics and director of phase I clinical trials, is overseeing the University of Arizona Cancer Center’s early-phase clinical trials, seeking to identify novel drugs and treatments for better cancer care.
The University of Arizona Sarver Heart Center continues its 2020 Green Valley Lecture Series with a focus on heart rhythm disorders. Dr. Peter Ott will speak on the most common arrhythmia, atrial fibrillation.
On Friday, March 20, medical students at the University of Arizona College of Medicine – Tucson will tear open envelopes simultaneously revealing where they will go for their residency training. Surrounded by friends and family, the emotion-filled ceremony is considered the most exciting day of medical school.
The University of Arizona Sarver Heart Center continues its 2020 Green Valley Lecture Series with a focus on stroke, how it affects health and treatment options to reverse stroke symptoms.
The $26-million expansion includes new chemistry laboratory space that will be used for drug discovery and development and research in the areas of pharmaceutics, pharmacogenomics and pharmacology.